» Articles » PMID: 25527980

A Simple LC-MS/MS Method Using HILIC Chromatography for the Determination of Fosfomycin in Plasma and Urine: Application to a Pilot Pharmacokinetic Study in Humans

Overview
Specialty Chemistry
Date 2014 Dec 22
PMID 25527980
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

A high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method, using hydrophilic interaction liquid chromatography (HILIC) chromatography for the analysis of fosfomycin in human plasma and urine, has been developed and validated. The plasma method uses a simple protein precipitation using a low volume sample (10 μL) and is suitable for the concentration range of 1 to 2000 μg/mL. The urine method involves a simple dilution of 10 μL of sample and is suitable for a concentration range of 0.1 to 10 mg/mL. The plasma and urine results, reported, respectively, are for recovery (68, 72%), inter-assay precision (≤9.1%, ≤8.1%) and accuracy (range -7.2 to 3.3%, -1.9 to 1.6%), LLOQ precision (4.7%, 3.1%) and accuracy (1.7% and 1.2%), and includes investigations into the linearity, stability and matrix effects. The method was used in a pilot pharmacokinetic study of a critically ill patient receiving i.v. fosfomycin, which measured a maximum and minimum plasma concentration of 222 μg/mL and 172 μg/mL, respectively, after the initial dose, and a maximum and minimum plasma concentration of 868 μg/mL and 591μg/mL, respectively, after the fifth dose. The urine concentration was 2.03 mg/mL after the initial dose and 0.29 mg/mL after the fifth dose.

Citing Articles

Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy.

Manca A, Palermiti A, Mula J, Cusato J, Maiese D, Simiele M Pharmaceutics. 2023; 15(9).

PMID: 37765315 PMC: 10537177. DOI: 10.3390/pharmaceutics15092347.


Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model.

Abbott I, van Gorp E, Wyres K, Wallis S, Roberts J, Meletiadis J J Antimicrob Chemother. 2022; 77(5):1324-1333.

PMID: 35211736 PMC: 9047678. DOI: 10.1093/jac/dkac045.


Quantification of Fosfomycin in Combination with Nine Antibiotics in Human Plasma and Cation-Adjusted Mueller-Hinton II Broth via LCMS.

Goh K, Toh W, Hee D, Ting E, Chua N, Zulkifli F Antibiotics (Basel). 2022; 11(1).

PMID: 35052932 PMC: 8772704. DOI: 10.3390/antibiotics11010054.


Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection.

Kuiper S, Dijkmans A, Wilms E, Kamerling I, Burggraaf J, Stevens J J Antimicrob Chemother. 2020; 75(11):3278-3285.

PMID: 32712666 PMC: 9297308. DOI: 10.1093/jac/dkaa294.


Compensate for or Minimize Matrix Effects? Strategies for Overcoming Matrix Effects in Liquid Chromatography-Mass Spectrometry Technique: A Tutorial Review.

Cortese M, Gigliobianco M, Magnoni F, Censi R, Di Martino P Molecules. 2020; 25(13).

PMID: 32635301 PMC: 7412464. DOI: 10.3390/molecules25133047.